title: Dear-Doctor-Letter Fumaderm® - What are the facts?
authors: Psoriasis-Center, Department of Dermatology, Medical, University Medical Center Schleswig-Holstein, Campus Kiel.
authors: Ulrich
authors: U
authors: Mrowietz
authors: Dermatologikum Hamburg.
authors: Kristian
authors: K
authors: Reich
mesh_terms: D003879:Dermatologic Agents / Q000009:adverse effects / Q000627:therapeutic use; D000069462:Dimethyl Fumarate / Q000009:adverse effects* / Q000627:therapeutic use*; D019317:Evidence-Based Medicine; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use; D007970:Leukopenia / Q000139:chemically induced* / Q000517:prevention & control*; D009617:Nocardia Infections / Q000139:chemically induced* / Q000517:prevention & control; D011565:Psoriasis / Q000150:complications / Q000188:drug therapy*; D018570:Risk Assessment; D016896:Treatment Outcome
chemical_list: D003879:Dermatologic Agents; D007166:Immunosuppressive Agents; D000069462:Dimethyl Fumarate